What’ s new?
Page 2 Newsletter 4 / 2013
EUROGIA +( EUREKA Cluster)
EUROGIA + is a EUREKA Cluster for Low-Carbon Energy Technologies. It facilitates the deployment of existing technologies and supports the development of highly innovative new technical solutions by encouraging cooperation and coordination among European companies. The EUREKA‘ Label’ is awarded to project proposals with the potential of developing breakthrough innovations. It allows successful consortia to apply for national funding( funding is based on the OCS of the MOITAL rules). * Notice: large enterprises must be members of the cluster. All other entities will pay the cluster 1.1 % of the overall grant( if won). The 2013 open call for proposals is continuously open for submission all year round, with 4 cut-off dates. Next cut-off is 24 / 5 / 2013. EUROGIA + website: http:// www. eurogia. com / Call for proposals and rules of participation: http:// www. eurogia. com / submitting / criteria. html
What’ s new?
� Experts for Horizon 2020 Advisory Groups: Call for expressions of interest
The European Commission is widening its search for experts from all fields to participate in shaping the agenda of Horizon 2020, the European Union ' s future funding program for research and innovation. The experts of the advisory groups will provide high quality and timely advice for the preparation of the Horizon 2020 calls for project proposals. To reach the broadest range of profiles suited to contribute to the European Union ' s vision and objectives for Horizon 2020, the Commission is calling for expressions of interest with the aim of creating lists of high level experts that will participate in each of these groups. Each advisory group shall be representative of the broad constituency of stakeholders, including industry and research actors as well as representatives of civil society. The call for expressions of interest is open for the lifetime of the Horizon 2020 program. Experts can register at any time; expressions of interest will be taken into account for the renewal of groups at the end of each mandate. Further information about expertise and profiles sought, as well as instructions for registration can be found here: http:// ec. europa. eu / research / horizon2020 / index _ en. cfm? pg = h2020-experts
�
Innovation Medicine Initiative( IMI) consultation toward H2020 The Innovative Medicines Initiative( IMI) set up under FP7 has demonstrated the value of public private partnerships in advancing biomedical research. IMI provides an ideal framework for large scale open collaborations between industry and public partners, and delivers results directly applicable in pharmaceutical R & D, as well as in regulatory and clinical practice with high efficiency. Based on the success of IMI, it was envisage renewing this experience under H2020. After preliminary internal and on line consultations with some stakeholder groups, a general framework was built around 7 axis of activity( from reclassification of diseases, through safety and efficacy, to product development). However your input on the current proposal, in order to help define the key areas which will eventually be included in the final version of the program will be
appreciated. Here you will find the results of the consultations an address for your comments: http:// www. efpia. eu / public-consultations / sra-public-consultation